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INTRODUCTION 
    
  SDS provides optimal log BB correlation by MLC on a C18-
  column 
  Comparable log BB correlation was obtained on an IAM 
  column using a DPBS buffer with 30% MeOH 
  The combination of  methods with different interaction mecha-
  nisms does not lead to improved correlation coefficients 
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The Blood-Brain Barrier (BBB) permeability evaluation is an essential task for 
developing effective drugs for the treatment of the Central Nervous System 
(CNS). Both for drugs already on the market or under development, it is 
essential to know to what extent a drug enters the BBB. A common measure 
of the degree of BBB permeation is the ratio of the steady-state concentration 
of the drug molecule in the brain to the concentration in the blood, usually 
expressed as log (Cbrain/blood) or log BB [1]. 
 
In this study, 45 compounds with available in vivo log BB values are analyzed 
with both Micellar Liquid Chromatography (MLC) and Immobilized Artificial 
Membrane (IAM) Liquid Chromatography. The capabilities towards log BB 
prediction are compared for both in vitro methods [2]. 
 
MLC is a mode of Reversed Phase Liquid Chromatography (RPLC) which 
uses a surfactant solution above the Critical Micellar Concentration (CMC) as 
mobile phase. The CMC phase allows for purely aqueous elution of most 
compounds within acceptable elution times on C18 columns. The drug 
interactions in MLC are presented in Figure 1A [3]. 
 
IAMs mimic the lipid environment of a cell membrane. They are prepared by 
linking phospholipid analogues to silica particles. This can be used as an 
HPLC column packing material (Figure 1B) [4]. 
Figure 1: Schematic representation of  drug interactions in Micellar Liquid Chromatography (MLC) (A) and in Immobilized 
Artificial Membrane (IAM) liquid chromatography (B) 
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MLC measurements were performed on a GraceSmart C18 column (3 µm, 150 
mm x 2.1 mm), the mobile phase flow rate was 0.2 ml/min. Three types of 
surfactants were used at a concentration of 0.05 M: Sodium Dodecyl Sulfate 
(SDS), polyoxy-ethylene (23) lauryl ether (Brij35) and Sodium DeoxyCholate 
(SDC). The surfactants were dissolved in a phosphate or borate buffer 
solution and the pH was set at 7.4. 
 
RESULTS & DISCUSSION 
CONCLUSION 
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1: Drug molecule 
2: Phosphatidylcholine 
3: Aminopropyl silica 
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1: Micelle 
2: Surfactant monomer 
3: Drug molecule 
4: C18-column 
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(A) (B) 
IAM liquid chromatography measurements were performed on a Regis 
IAM.PC.DD2 column (10 µm, 150 mm x 4.6 mm), the mobile phase flow rate 
was 1 ml/min. The mobile phase was a mixture of methanol and Dulbecco’s 
Phosphate-Buffered Saline (DPBS). Measurements were performed with 20, 
30 or 40% methanol. 
MLC 
IAM 
The retention factors (k) of the compounds were measured. A Partial Least 
Squares (PLS) regression was performed in order to determine the correlation 
coefficient (R) between the experimental (in vivo) log BB values and log BB 
values predicted using log k values and several molecular descriptors. The 
most relevant descriptors were selected by systematic removal and/or 
reinsertion of all descriptors from the models while monitoring the effect on 
the Leave-One-Out Cross-Validation (LOOCV) regression coefficients. 
Log BB 
The results from the PLS and LOOCV regressions are given in Table 1.  
The test set consisted of 45 compounds. Since an accurate prediction of log 
BB values for any type of drug is necessary, the conditions that allowed to 
measure all 45 compounds were considered most interesting (indicated in 
gray). Measurements with SDS as surfactant allowed for the best correlation, 
but results from the IAM column were comparable. Extrapolation of IAM 
results to 0 % MeOH hardly improved the correlation coefficient. 
 
The correlation between in vivo and predicted log BB values is illustrated in 
Figure 2 for the 0.05 M SDS mobile phase before and after optimization. 
Although there are a few outsiders, the predicted log BB values for most 
compounds are close to the experimentally (in vivo) determined values.  
 
Table 1: Correlation coefficients between in vivo log BB values and predicted log BB values using log k values and several 
molecular descriptors 
Prediction of  log BB values 
The coefficients of the equations obtained from PLS regressions that lead to 
the R values listed in Table 1, are listed in Table 2. The general equation for 
Table 2 is: predicted log BB = a + b×α + c×Polarizability + d×log Wso + 
e×WS7.4 + f×PB + g×HIA + h×log k1 (+ i×log k2). Except for the log k 
values, all descriptor values are available in literature or can be calculated.  
Figure 2: Visual representation of  the correlation between ‘In vivo’ and ‘Predicted’ log BB values using the LOOCV method with 
log k values from 0.05 M SDS mobile phase on a C18 column before (A) and after (B) elimination of  superfluous descriptors 
(B) (A) 
  Brij35 SDC SDS IAM IAM IAM IAM SDS + IAM SDS + IAM 
  0.05 M 0.05 M 0.05 M 40 % MeOH 30 % MeOH 20 % MeOH 0 % MeOH 40 % MeOH 30 % MeOH 
# compounds 43 36 45 45 45 39 45 45 45 
R (PLS) 0.7870 0.8862 0.8564 0.8602 0.8659 0.8389 0.8621 0.8825 0.8848 
R (LOOCV) 0.6620 0.7842 0.7993 0.7533 0.7724 0.7451 0.7831 0.7916 0.7982 
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Table 2: Coefficients generated by PLS regression after elimination of  several descriptors. The general 
equation for the predicted log BB values is:  
log BB = a + b×α + c×Polarizability + d×log WSo + e×WS7.4 + f×PB + g×HIA + h×log k1 (+ i×log k2) 
  Brij35 SDC SDS IAM IAM IAM IAM SDS + IAM SDS + IAM 
  0.05 M 0.05 M 0.05 M 40 % MeOH 30 % MeOH 20 % MeOH 0 % MeOH 40 % MeOH 30 % MeOH 
a -3.666 -3.800 -3.911 -3.039 -2.995 -2.809 -2.859 -3.350 -3.302 
b 0.589 0.241 0.397 0.455 0.495 0.437 0.600 0.324 0.358 
c -0.039 -0.053 -0.050 -0.044 -0.051 -0.053 -0.069 -0.046 -0.051 
d 0.099 0.063 0.080 0.155 0.152 0.146 0.133 0.146 0.144 
e -0.002 -0.003 -0.003 -0.003 -0.002 -0.002 -0.002 -0.003 -0.003 
f 0.007 0.007 0.011 0.003 0.002 0.003 0.004 0.005 0.005 
g 0.044 0.048 0.044 0.047 0.046 0.042 0.042 0.045 0.045 
h 0.530 0.439 0.571 0.709 0.705 0.517 0.604 0.453 0.466 
i - - - - - - - 0.344 0.323 
